Inhibitors of cyclin dependent kinases as anti-cancer agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 28, 2007
Grant Date -
Jul 8, 2004
app pub date -
Sep 24, 2003
filing date -
Mar 29, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukaemia, psoriasis and the like.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully